Orthofix International NV said the U.S. Food and Drug Administration granted 510(k) clearance to its G-Beam fusion beaming system to treat Charcot foot, a condition where the bones in the foot weaken and collapse.
The Lewisville, Texas-based device-maker said the G-Beam devices can be implanted in the medial and lateral columns of the foot to provide alignment, stabilization and fixation.